Literature DB >> 8253202

Human lymphocyte antigen CD38 catalyzes the production of cyclic ADP-ribose.

R J Summerhill1, D G Jackson, A Galione.   

Abstract

The human lymphocyte antigen CD38 has been shown to share sequence homology with ADP-ribosyl cyclase, the enzyme that catalyzes the conversion of NAD+ to cyclic ADP-ribose (cADPR), a potent Ca(2+)-mobilizing agent. In this study COS1 cells from African Green Monkey kidney were transiently transfected with CD38 cDNA, inducing expression of authentic CD38 on the cell surface. We demonstrate that CD38 expressed in this manner can convert NAD+ to cADPR in the extracellular medium as assessed by Ca2+ release from sea-urchin egg microsomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253202     DOI: 10.1016/0014-5793(93)80735-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Differential regulation of nicotinic acid-adenine dinucleotide phosphate and cADP-ribose production by cAMP and cGMP.

Authors:  H L Wilson; A Galione
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

2.  Human CD38 is an authentic NAD(P)+ glycohydrolase.

Authors:  V Berthelier; J M Tixier; H Muller-Steffner; F Schuber; P Deterre
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 3.  CD38 autoimmunity: recent advances and relevance to human diabetes.

Authors:  A Antonelli; E Ferrannini
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

4.  Extracellular synthesis of cADP-ribose from nicotinamide-adenine dinucleotide by rat cortical astrocytes in culture.

Authors:  L Pawlikowska; S E Cottrell; M B Harms; Y Li; P A Rosenberg
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

5.  Ectocellular in vitro and in vivo metabolism of cADP-ribose in cerebellum.

Authors:  A De Flora; L Guida; L Franco; E Zocchi; M Pestarino; C Usai; C Marchetti; E Fedele; G Fontana; M Raiteri
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

6.  Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.

Authors:  K A Wall; M Klis; J Kornet; D Coyle; J C Amé; M K Jacobson; J T Slama
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

7.  Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.

Authors:  Leman Yalçintepe; Emre Halis; Sibel Ulku
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

8.  Ligation of CD38 suppresses human B lymphopoiesis.

Authors:  M Kumagai; E Coustan-Smith; D J Murray; O Silvennoinen; K G Murti; W E Evans; F Malavasi; D Campana
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

9.  Okamoto model for necrosis and its expansions, CD38-cyclic ADP-ribose signal system for intracellular Ca2+ mobilization and Reg (Regenerating gene protein)-Reg receptor system for cell regeneration.

Authors:  Hiroshi Okamoto; Shin Takasawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2021       Impact factor: 3.493

10.  CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype.

Authors:  L Galibert; N Burdin; B de Saint-Vis; P Garrone; C Van Kooten; J Banchereau; F Rousset
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.